Cargando…
Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in Ethiopia: a retrospective follow-up study
BACKGROUND: Over 420,000 people have initiated life-saving antiretroviral therapy (ART) in Ethiopia; however, lost-to-follow-up (LTFU) rates continues to be high. A clinical decision tool is needed to identify patients at higher risk for LTFU to provide individualized risk prediction to intervention...
Autores principales: | Fentie, Dawit Tefera, Kassa, Getahun Molla, Tiruneh, Sofonyas Abebaw, Muche, Achenef Asmamaw |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449961/ https://www.ncbi.nlm.nih.gov/pubmed/36071386 http://dx.doi.org/10.1186/s12879-022-07691-x |
Ejemplares similares
-
Half-life time prediction of developing first-line antiretroviral treatment failure and its risk factors among TB and HIV co-infected children in Northwest Ethiopia; multi setting historical follow-up study
por: Chanie, Ermias Sisay, et al.
Publicado: (2022) -
Spatial distribution and geographical heterogeneity factors associated with poor consumption of foods rich in vitamin A among children age 6–23 months in Ethiopia: Geographical weighted regression analysis
por: Tiruneh, Sofonyas Abebaw, et al.
Publicado: (2021) -
Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study
por: Kassa, Getahun Molla, et al.
Publicado: (2019) -
Sputum smear grading and associated factors among bacteriologically confirmed pulmonary drug-resistant tuberculosis patients in Ethiopia
por: Kassa, Getahun Molla, et al.
Publicado: (2021) -
Incidence and predictors of lost to follow-up among women under Option B+ PMTCT program in western Ethiopia: a retrospective follow-up study
por: Tolossa, Tadesse, et al.
Publicado: (2020)